DIABETIC KIDNEY DISEASE (DKD)
Clinical trials for DIABETIC KIDNEY DISEASE (DKD) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC KIDNEY DISEASE (DKD) trials appear
Sign up with your email to follow new studies for DIABETIC KIDNEY DISEASE (DKD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough drugs target kidney damage in diabetes
Disease control Recruiting nowThis study is testing two experimental drugs, ALN-ANG3 and evinacumab, to see if they can help control diabetic kidney disease. The main goal is to see if the drugs safely reduce protein in the urine, a key sign of kidney damage. The trial will involve about 270 adults with type …
Matched conditions: DIABETIC KIDNEY DISEASE (DKD)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Stem cell shot tested to halt kidney damage in diabetes
Disease control Recruiting nowThis study is testing whether an experimental treatment using umbilical cord stem cells (called Amimestrocel) can help slow or improve kidney damage in people with diabetic kidney disease. It will involve about 120 participants to see if the treatment is safe and if it can reduce…
Matched conditions: DIABETIC KIDNEY DISEASE (DKD)
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC